Vaxcyte, Inc. (PCVX)
71.63
+6.62
(+10.17%)
USD |
NASDAQ |
Oct 09, 15:20
Vaxcyte EPS Diluted (Quarterly) : -1.968 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.968 |
| March 31, 2026 | -2.298 |
| December 31, 2025 | -1.881 |
| September 30, 2025 | -1.563 |
| June 30, 2025 | -1.224 |
| March 31, 2025 | -1.037 |
| December 31, 2024 | -1.098 |
| September 30, 2024 | -0.8337 |
| June 30, 2024 | -1.098 |
| March 31, 2024 | -0.8507 |
| December 31, 2023 | -1.896 |
| September 30, 2023 | -0.9114 |
| June 30, 2023 | -0.6969 |
| March 31, 2023 | -0.7014 |
| December 31, 2022 | -1.028 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.9343 |
| June 30, 2022 | -0.798 |
| March 31, 2022 | -0.6774 |
| December 31, 2021 | -0.5422 |
| September 30, 2021 | -0.51 |
| June 30, 2021 | -0.4597 |
| March 31, 2021 | -0.4147 |
| December 31, 2020 | -0.406 |
| September 30, 2020 | -0.4125 |
| June 30, 2020 | -0.3994 |
| March 31, 2020 | -0.5555 |
| December 31, 2019 | -0.2993 |
| September 30, 2019 | -0.2316 |
| June 30, 2019 | -0.2102 |
| March 31, 2019 | -0.2798 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Moderna, Inc. | -1.965 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -284.30M |
| Total Expenses (Quarterly) | 284.30M |
| Enterprise Value | 8.042B |
| Earnings Yield | -10.76% |
| Normalized Earnings Yield | -10.76 |